ArticleHeart (British Cardiac Society)2017

Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?

David Charles Hutchings et al.PubMed ↗Publisher ↗

No numbers read from the abstract.